radium has been researched along with Cystadenocarcinoma, Serous in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Biagioli, M; Coleman, RL; Elshaikh, M; Gaffney, D; Harkenrider, M; Jhingran, A; Jolly, S; Kidd, EA; Li, L; Portelance, L; Sherertz, T; Small, W; Venkatesan, A; Wahl, A; Yashar, C | 1 |
1 other study(ies) available for radium and Cystadenocarcinoma, Serous
| Article | Year |
|---|---|
Executive summary of the American Radium Society appropriate use criteria for management of uterine clear cell and serous carcinomas.
Topics: Chemotherapy, Adjuvant; Cystadenocarcinoma, Serous; Endometrial Neoplasms; Female; Humans; Hysterectomy; Neoplasm Staging; Prospective Studies; Radiotherapy, Adjuvant; Radium; Retrospective Studies; Uterine Neoplasms | 2022 |